Aeterna Zentaris logo
Aeterna Zentaris AEZS

Annual report 2024
added 03-21-2026

report update icon

Aeterna Zentaris Depreciation & Amortization 2011-2026 | AEZS

Annual Depreciation & Amortization Aeterna Zentaris

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - 58 K 94 K 280 K 341 K - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
341 K 58 K 193 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer Depreciation & Amortization Price % 24h Market Cap Country
Amgen Amgen
AMGN
5.17 B $ 350.62 0.81 % $ 189 B usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
2.31 M $ 0.8 2.35 % $ 133 M usaUSA
Altimmune Altimmune
ALT
112 K $ 3.46 3.44 % $ 305 M usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
27 K - 1052.0 % $ 415 M usaUSA
Incyte Corporation Incyte Corporation
INCY
93.3 M $ 90.74 -0.04 % $ 17.7 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
131 K - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
2.62 M $ 1.62 2.22 % $ 35.9 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
63 K - 10.36 % $ 9.8 M usaUSA
Acasti Pharma Acasti Pharma
ACST
7 K - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
66 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Cullinan Management Cullinan Management
CGEM
311 K $ 12.92 1.41 % $ 778 M usaUSA
Atreca Atreca
BCEL
5.46 M - -11.76 % $ 5.79 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
140 K - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
142 M - 0.49 % $ 251 B cayman-islandsCayman-islands
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
941 K $ 16.76 -1.41 % $ 832 M britainBritain
Calithera Biosciences Calithera Biosciences
CALA
300 K - -10.95 % $ 876 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
259 K - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.14 M - - $ 3.74 B usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
340 K $ 7.06 -7.47 % $ 860 K usaUSA
Clovis Oncology Clovis Oncology
CLVS
8.5 M - -7.23 % $ 13 M usaUSA
Keros Therapeutics Keros Therapeutics
KROS
1.51 M $ 11.27 2.83 % $ 419 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
7.8 M $ 21.23 5.26 % $ 3.49 B usaUSA
Longeveron Longeveron
LGVN
800 K $ 0.95 -3.52 % $ 16.7 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
1.4 M $ 4.3 1.3 % $ 714 M canadaCanada
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA